Asset Dedication LLC Has $279,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Asset Dedication LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 94.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 534 shares of the medical equipment provider’s stock after acquiring an additional 259 shares during the quarter. Asset Dedication LLC’s holdings in Intuitive Surgical were worth $279,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of ISRG. Mirador Capital Partners LP boosted its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the period. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical in the 4th quarter valued at $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the 4th quarter valued at $82,517,000. Exome Asset Management LLC increased its position in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, Consolidated Planning Corp lifted its holdings in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on ISRG shares. CICC Research initiated coverage on shares of Intuitive Surgical in a research note on Monday. They issued a “neutral” rating and a $550.00 price objective for the company. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday. Finally, Royal Bank of Canada increased their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Down 0.2 %

Shares of NASDAQ ISRG opened at $572.71 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a fifty day simple moving average of $548.70 and a two-hundred day simple moving average of $507.04. The firm has a market capitalization of $203.99 billion, a PE ratio of 92.08, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 28,843 shares of company stock valued at $15,357,560. 0.90% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.